STUBBINGTON MEDICAL PRACTICE — All Prescriptions & Medications — Page 8
Practice Code: J82104 | FAREHAM, PO14 2JP
Showing results 351-400 of 613
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Prasugrel | 58 | 2,674 | £377 | +84.5% ▲ |
| Naratriptan hydrochloride | 58 | 576 | £113 | +121.8% ▲ |
| Rotigotine | 58 | 1,988 | £8.1K | +114.9% ▲ |
| Miconazole nitrate | 58 | 2,040 | £324 | -18.0% ▼ |
| Nefopam hydrochloride | 55 | 1,636 | £74 | -51.4% ▼ |
| 55 | 569 | £400 | +35.1% ▲ | |
| 55 | 1,495 | £206 | +104.7% ▲ | |
| Metoprolol tartrate | 54 | 770 | £79 | +6.5% ▲ |
| Mefenamic acid | 54 | 4,453 | £849 | +19.5% ▲ |
| Orlistat | 53 | 5,460 | £1.3K | -35.7% ▼ |
| Galantamine | 53 | 966 | £764 | +40.1% ▲ |
| Semaglutide | 53 | 1,961 | £10.1K | -78.0% ▼ |
| Carvedilol | 51 | 5,768 | £172 | -55.1% ▼ |
| Powder extensively hydrolysed formula (0913101) | 51 | 115.6K | £3.3K | -29.2% ▼ |
| 51 | 670 | £406 | +18.3% ▲ | |
| Midodrine hydrochloride | 50 | 3,210 | £709 | +2.6% ▲ |
| Insulin detemir | 50 | 370 | £3.1K | -36.2% ▼ |
| 50 | 270 | £267 | +52.4% ▲ | |
| 49 | 125 | £1.8K | +540.7% ▲ | |
| 48 | 578 | £826 | +72.5% ▲ | |
| 48 | 22.8K | £166 | -47.4% ▼ | |
| Other individually formulated bought in preparations | 47 | 1,750 | £4.9K | +43.9% ▲ |
| 47 | 3,400 | £157 | -13.4% ▼ | |
| 47 | 4,631 | £297 | -78.3% ▼ | |
| Telmisartan | 46 | 2,408 | £628 | -20.7% ▼ |
| Valsartan | 46 | 3,846 | £929 | -21.9% ▼ |
| Salmeterol | 46 | 77 | £2.0K | +91.3% ▲ |
| Medroxyprogesterone acetate | 46 | 3,493 | £671 | +20.2% ▲ |
| Gentamicin sulfate | 46 | 520 | £989 | +737.1% ▲ |
| Acamprosate calcium | 45 | 2,030 | £236 | +29.2% ▲ |
| Ketone blood testing reagents | 45 | 2,010 | £2.7K | -33.5% ▼ |
| Liothyronine sodium | 45 | 3,304 | £10.9K | +111.0% ▲ |
| Duloxetine hydrochloride | 45 | 3,050 | £730 | -12.2% ▼ |
| Brinzolamide | 44 | 440 | £350 | -66.1% ▼ |
| Clomipramine hydrochloride | 43 | 2,191 | £363 | +2.0% ▲ |
| Valaciclovir | 43 | 2,632 | £3.6K | +206.0% ▲ |
| Hyoscine | 42 | 362 | £2.3K | +505.1% ▲ |
| Erythromycin | 42 | 5,200 | £1.9K | +21.2% ▲ |
| Mycophenolate mofetil | 42 | 9,348 | £2.1K | +3.7% ▲ |
| Olopatadine | 42 | 305 | £278 | -4.3% ▼ |
| 42 | 650 | £733 | +139.0% ▲ | |
| Sodium citrate (Rectal) | 41 | 349 | £233 | +197.1% ▲ |
| Umeclidinium bromide | 41 | 70 | £1.8K | -33.5% ▼ |
| Hyoscine hydrobromide | 41 | 1,532 | £239 | +20.1% ▲ |
| Phenobarbital | 41 | 2,312 | £590 | +33.3% ▲ |
| Benzalkonium chloride | 41 | 13.5K | £302 | +257.5% ▲ |
| Metronidazole | 41 | 1,755 | £827 | +9.1% ▲ |
| 41 | 167 | £1.0K | -40.1% ▼ | |
| 41 | 660 | £162 | +217.5% ▲ | |
| Opicapone | 40 | 1,774 | £3.5K | +109.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.